Short term swing trade (A): Healthcare stock | Indian stock trading calls on 8 Nov 2026

NOTE

Closing Price: ₹516.35 (as of Nov 06, 2026)
StopLoss*: Apply on the daily close. After the first target, reset the StopLoss to your buying price.
Duration^: Approximate holding period based on the active trading days (excluding market holidays). Actual holding may vary with the market conditions.
Upside Potential#: Based on median of the suggested buy range.

Dr. Agarwal’s Health Care operates eye hospitals, optical stores, and pharmacies in India and international markets. Its services include eye consultations, diagnosis, cataract and retinal surgeries, corneal transplants, and other eye treatments. The company also manufactures and sells ophthalmic medical devices, spectacles, contact lenses, and eye care medicines. Incorporated in 2010, it is headquartered in Chennai, India.

Q2 FY27 Earnings Call Summary & Financial Highlights

Earnings Call Summary

Strong growth: Revenue more than doubled to ₹157 crore, while net profit nearly tripled to ₹44 crore year-on-year.
Profit margins improved: Operating margin increased to 40% from 33%, and EPS rose to ₹0.33 from ₹0.11.
Demand remains healthy: Growth was driven by international B2B healthcare demand and domestic consumer healthcare and FMCG businesses.
FY27 targets raised: Management increased its revenue target to ₹725–750 crore and net profit target to ₹210–225 crore, supported by expansion and strong order visibility.
Raw material costs to watch: Rising natural rubber prices could increase costs. However, the company’s inventory buffer may provide some protection in the near term.

Financial Highlights

Metric	Q2 FY27 (Sep ‘26)	Q1 FY27 (Jun ‘26)	Q2 FY26 (Sep ‘25)	QoQ Change	YoY Change
Revenue from Operations	655	614	499	▲ 6.7%	▲ 31.3%
EBITDA (Operating Profit)	176	170	136	▲ 3.5%	▲ 29.4%
EBITDA Margin (OPM %)	27%	28%	27%	▼ 100 bps	—
Net Profit (PAT)	57	55	36	▲ 3.6%	▲ 58.3%
EPS (₹)	1.73	1.63	1.1	▲ 6.1%	▲ 57.3%

Price Performance & Volume Analysis

Price Performance

Volume Analysis

Technical Analysis

Key Observations

Ascending triangle pattern: Price is consolidating below a horizontal resistance, while higher lows form along a rising trendline, creating an ascending triangle.
Trendline support holds: The latest pullback found strong buying support at the ascending trendline, triggering a sharp rebound.
Resistance remains intact: Price is recovering but has yet to break horizontal resistance. A further move towards this level is likely in the short term.

With reliable positional stock tips in India, traders can stay aligned with short-term trends that build quietly but steadily.

Technical Image - Daily Timeframe

Technical Indicators

Oscillators

Indicator	Value	Zone
RSI-14	63.62	Neutral
CCI-14	101.43	Overbought
MFI	80.85	Overbought
ROC	11.16	Positive
Stochastic %K	84.27	Overbought
William %R	-16.81	Overbought

Exponential Moving Averages (EMAs)

EMA	Value	Stock Position
5 EMA	512.26	Above
10 EMA	503.56	Above
20 EMA	495.16	Above
50 EMA	492.26	Above
100 EMA	488.19	Above
200 EMA	477.11	Above

Conclusion

Dr. Agarwal's Health Care Stock Price Forecast

Based on our stock market advisory services, the Dr. Agarwal's Health Care stock price target will be INR 540 - INR 550 in the next 14-15 trading sessions.

MONEY MANAGEMENT AND TRADING RULES

Buy within the recommended price range. You may allow up to 1% flexibility beyond the range if needed.
No need to rush. The recommendation remains valid for up to 7 days, not just at market open.
Use a trailing stop-loss to protect and lock in profits.
Diversify your trading capital across our other recommended stocks to reduce risk.
Invest responsibly. Trade only with funds you can afford to lose and hedge positions where appropriate.

Analyst Summary

The research analysis is prepared by Arijit Banerjee, CMT, CFTe. He is a veteran trader and an active investor having in-depth knowledge in financial market research, advanced technical analysis, market cycle, algorithmic trading and portfolio management. Arijit is a Chartered Market Technician (CMT) accredited by CMT Association USA, the leading global authority of Technical Analysis and has been honoured by Certified Financial Technician (CFTe) from the International Federation of Technical Analysts, USA. SEBI, the regulatory body of Indian financial market also recognizes him as a Research Analyst (INH300006582).

The views expressed herein are based solely on information available publicly/internal data/other sources believed to be reliable, but is not necessarily all-inclusive and is not guaranteed as to accuracy. The recommendations provided herein is solely for informational purposes and are not intended to be and must not be taken alone as the basis for an investment/trading decision. Trading and investing are subject to market risk and the securities discussed and opinions expressed herein may not be suitable for all investors. To read the full disclosure, please click here.

Your Return Could be Much Better

Increase your Profitable!

10—12 swing trade advice / month
expected upside 6%—8% per trade
short term trade holding 1-2 weeks
minimum capital required ₹ 3-lakh
receive trade advice before 9:00 am
trade ideas by blackbox system, relied on statistics, technical, fundamental, macroeconomics and sentiment
Stocks only — no intraday or F&O